Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Lymphadenopathy Follow-up

  • Author: Vikramjit S Kanwar, MBBS, MBA, MRCP(UK), FAAP; Chief Editor: Russell W Steele, MD  more...
 
Updated: Jun 14, 2016
 

Further Outpatient Care

Further outpatient treatment depends on establishing a diagnosis and determining management of that diagnosis.

Next

Further Inpatient Care

Additional inpatient treatment depends on establishing the diagnosis and determining management based on that diagnosis.

Previous
Next

Inpatient & Outpatient Medications

Inpatient and ambulatory medications depend on the specific underlying etiology of the lymphadenopathy.

Previous
Next

Transfer

Transfer of the patient usually depends on the specific diagnosis. Patients who develop superior vena cava syndrome with either respiratory symptoms or obstruction to blood flow require emergency medical care and may require transfer to a tertiary care center.

Previous
Next

Complications

Complications are usually related to the specific underlying disorder causing the lymphadenopathy; however, the lymphadenopathy itself can cause potentially serious complications.

  • Mediastinal adenopathy can result in several potentially life-threatening complications. Recognition of these complications is important because mediastinal adenopathy cannot be directly assessed clinically and therefore may be easily missed.
  • Mediastinal adenopathy can cause superior vena cava syndrome with obstruction of blood flow; bronchial or tracheal obstruction with cough, wheezing, and ultimately respiratory tract obstruction (which can be life threatening); and dysphagia from esophageal compression. Occasionally, erosion of a node into a bronchus or trachea can result in hemoptysis.
  • When the diagnosis of an underlying malignancy is missed, serious metabolic complications can occur. These include uric acid nephropathy, hyperkalemia, hypercalcemia, hypocalcemia, hyperphosphatemia, and acid renal failure.
  • Abdominal adenopathy can cause abdominal or back pain, constipation, and urinary frequency. Intestinal obstruction caused by intussusception can be life threatening.
Previous
Next

Prognosis

The prognosis of lymphadenopathy almost entirely depends on the underlying etiology. Patients with specific complications, such as superior vena cava syndrome, are at risk unless this specific complication is managed. Their prognosis is dependent on the management of the neoplastic process resulting in superior vena cava syndrome.

Previous
Next

Patient Education

Patient and family education depends on the specific etiology of the lymphadenopathy.

Previous
 
Contributor Information and Disclosures
Author

Vikramjit S Kanwar, MBBS, MBA, MRCP(UK), FAAP Professor of Pediatrics, Albany Medical College; Chief, Division of Pediatric Hematology-Oncology, John and Anna Landis Endowed Chair for Pediatric Hematology-Oncology, Medical Director, Melodies Center for Childhood Cancer and Blood Disorders, Albany Medical Center

Vikramjit S Kanwar, MBBS, MBA, MRCP(UK), FAAP is a member of the following medical societies: American Academy of Pediatrics, American Society of Hematology, American Society of Pediatric Hematology/Oncology, Children's Oncology Group, International Society of Pediatric Oncology

Disclosure: Nothing to disclose.

Coauthor(s)

Richard H Sills, MD Professor of Pediatrics, Upstate Medical University

Richard H Sills, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society of Hematology, American Society of Pediatric Hematology/Oncology

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Larry I Lutwick, MD Professor of Medicine, State University of New York Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus

Larry I Lutwick, MD is a member of the following medical societies: American College of Physicians, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, Southern Medical Association

Disclosure: Nothing to disclose.

Additional Contributors

Gary J Noel, MD Professor, Department of Pediatrics, Weill Cornell Medical College; Attending Pediatrician, New York-Presbyterian Hospital

Gary J Noel, MD is a member of the following medical societies: Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Stephanie Jorgensen, MD, to the original writing and development of this article.

References
  1. Larsson LO, Bentzon MW, Berg Kelly K, et al. Palpable lymph nodes of the neck in Swedish schoolchildren. Acta Paediatr. 1994 Oct. 83(10):1091-4. [Medline].

  2. Grossman M, Shiramizu B. Evaluation of lymphadenopathy in children. Curr Opin Pediatr. 1994. 6(1):68-76. [Medline].

  3. Moore SW, Schneider JW, Schaaf HS. Diagnostic aspects of cervical lymphadenopathy in children in the developing world: a study of 1,877 surgical specimens. Pediatr Surg Int. 2003 Jun. 19(4):240-4. [Medline].

  4. Miller DR. Hematologic malignancies: leukemia and lymphoma (Differential diagnosis of lymphadenopathy). Miller DR, Baehner RL, eds. Blood Diseases of Infancy and Childhood. Mosby Inc; 1995. 745-9.

  5. Kliegman RM, Nieder ML, Super DM. Lymphadenopathy. Fletcher J, Bralow L, eds. Practical Strategies in Pediatric Diagnosis and Therapy. WB Saunders Co; 1996. 791-803.

  6. Roberts KB, Tunnessen WW. Lymphadenopathy. Signs and Symptoms in Pediatrics. 3rd ed. Lippincott, Williams, and Wilkins; 1999. 63-72.

  7. Nield LS, Kamat D. Lymphadenopathy in children: when and how to evaluate. Clin Pediatr (Phila). 2004 Jan-Feb. 43(1):25-33. [Medline].

  8. Oguz A, Karadeniz C, Temel EA, Citak EC, Okur FV. Evaluation of peripheral lymphadenopathy in children. Pediatr Hematol Oncol. 2006 Oct-Nov. 23(7):549-61. [Medline].

  9. Yaris N, Cakir M, Sozen E, Cobanoglu U. Analysis of children with peripheral lymphadenopathy. Clin Pediatr (Phila). 2006 Jul. 45(6):544-9. [Medline].

  10. Gray DM, Zar H, Cotton M. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children. Cochrane Database Syst Rev. 2009 Jan 21. CD006418. [Medline].

  11. Leung AK, Davies HD. Cervical lymphadenitis: etiology, diagnosis, and management. Curr Infect Dis Rep. 2009 May. 11(3):183-9. [Medline].

  12. Lindeboom JA, Kuijper EJ, Bruijnesteijn van Coppenraet ES, Lindeboom R, Prins JM. Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial. Clin Infect Dis. 2007 Apr 15. 44(8):1057-64. [Medline].

  13. Twist CJ, Link MP. Assessment of lymphadenopathy in children. Pediatr Clin North Am. 2002 Oct. 49(5):1009-25. [Medline].

  14. Razek AA, Gaballa G, Elashry R, Elkhamary S. Diffusion-weighted MR imaging of mediastinal lymphadenopathy in children. Jpn J Radiol. 2015 Jun 12. [Medline].

  15. Tsujikawa T, Tsuchida T, Imamura Y, Kobayashi M, Asahi S, Shimizu K. Kikuchi-Fujimoto disease: PET/CT assessment of a rare cause of cervical lymphadenopathy. Clin Nucl Med. 2011 Aug. 36(8):661-4. [Medline].

  16. Quarles van Ufford H, Hoekstra O, de Haas M, Fijnheer R, Wittebol S, Tieks B. On the added value of baseline FDG-PET in malignant lymphoma. Mol Imaging Biol. 2010 Apr. 12(2):225-32. [Medline].

  17. Niedzielska G, Kotowski M, Niedzielski A, Dybiec E, Wieczorek P. Cervical lymphadenopathy in children--incidence and diagnostic management. Int J Pediatr Otorhinolaryngol. 2007 Jan. 71(1):51-6. [Medline].

  18. Vayner N, Coret A, Polliack G, et al. Mesenteric lymphadenopathy in children examined by US for chronic and/or recurrent abdominal pain. Pediatr Radiol. 2003 Dec. 33(12):864-7. [Medline].

  19. Cui XW, Jenssen C, Saftoiu A, Ignee A, Dietrich CF. New ultrasound techniques for lymph node evaluation. World J Gastroenterol. 2013 Aug 14. 19(30):4850-60. [Medline]. [Full Text].

  20. Ying M, Cheng SC, Ahuja AT. Diagnostic Accuracy of Computer-Aided Assessment of Intranodal Vascularity in Distinguishing Different Causes of Cervical Lymphadenopathy. Ultrasound Med Biol. 2016 Apr 27. [Medline].

  21. Lange TJ, Kunzendorf F, Pfeifer M, Arzt M, Schulz C. Endobronchial ultrasound-guided transbronchial needle aspiration in routine care - plenty of benign results and follow-up tests. Int J Clin Pract. 2012 May. 66(5):438-45. [Medline].

  22. Dhooria S, Madan K, Pattabhiraman V, et al. A multicenter study on the utility and safety of EBUS-TBNA and EUS-B-FNA in children. Pediatr Pulmonol. 2016 May 3. [Medline].

Previous
Next
 
A lymph node biopsy is performed. Note that a marking pen has been used to outline the node before removal and that a silk suture has been used to provide traction to assist the removal.
A lymph node after removal by means of biopsy, which was performed completely under a local anesthetic technique.
A gross image of a node following excision. The cut surface of the node shows the typical fish-flesh appearance seen with lymphoma.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.